731 related articles for article (PubMed ID: 16227948)
1. The role of menopausal hormone therapy in preventing osteoporotic fractures: a critical review of the clinical evidence.
Col NF; Bowlby LA; McGarry K
Minerva Med; 2005 Oct; 96(5):331-42. PubMed ID: 16227948
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of hormone therapy in women at high risks of fracture in Sweden, the US and the UK--results based on the Women's Health Initiative randomised controlled trial.
Lekander I; Borgström F; Ström O; Zethraeus N; Kanis JA
Bone; 2008 Feb; 42(2):294-306. PubMed ID: 18053789
[TBL] [Abstract][Full Text] [Related]
3. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
[TBL] [Abstract][Full Text] [Related]
4. How to manage osteoporosis after the menopause.
Compston J
Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1007-19. PubMed ID: 16301194
[TBL] [Abstract][Full Text] [Related]
5. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
Levine JP
Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027
[TBL] [Abstract][Full Text] [Related]
6. [The effect of hormone replacement therapy on bone mineral content and on fractures].
Eiken PA
Ugeskr Laeger; 1997 Jan; 159(5):570-6. PubMed ID: 9045445
[TBL] [Abstract][Full Text] [Related]
7. Prevention of osteoporotic fractures in post-menopausal women.
Compston J
Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Jun; 14(2):251-64. PubMed ID: 11035905
[TBL] [Abstract][Full Text] [Related]
8. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
Bagger YZ; Tankó LB; Alexandersen P; Hansen HB; Møllgaard A; Ravn P; Qvist P; Kanis JA; Christiansen C
Bone; 2004 Apr; 34(4):728-35. PubMed ID: 15050905
[TBL] [Abstract][Full Text] [Related]
9. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
Josse RG
CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
Iwamoto J; Takeda T; Sato Y
Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
[TBL] [Abstract][Full Text] [Related]
11. Estrogen replacement therapy in the elderly.
Paganini-Hill A
Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
[TBL] [Abstract][Full Text] [Related]
12. Prevention and treatment of osteoporosis with hormone replacement therapy.
Christiansen C
Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():45-54. PubMed ID: 8499959
[TBL] [Abstract][Full Text] [Related]
13. Osteoporotic compression fractures of the spine; current options and considerations for treatment.
Kim DH; Vaccaro AR
Spine J; 2006; 6(5):479-87. PubMed ID: 16934715
[TBL] [Abstract][Full Text] [Related]
14. [Absolute risk for fracture and WHO guideline. Selection of drugs for the prevention of fractures in postmenopausal women].
Gorai I;
Clin Calcium; 2007 Jul; 17(7):1090-6. PubMed ID: 17607077
[TBL] [Abstract][Full Text] [Related]
15. [Hormone replacement therapy and its derivatives in the prevention and treatment of osteoporosis].
Lamy O; Krieg MA
Rev Med Suisse Romande; 2002 Aug; 122(8):377-81. PubMed ID: 12357730
[TBL] [Abstract][Full Text] [Related]
16. Bone health and osteoporosis in postmenopausal women.
de Villiers TJ
Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):73-85. PubMed ID: 19027366
[TBL] [Abstract][Full Text] [Related]
17. [Evidence of hormone replacement therapy for osteoporosis].
Tarakida A; Higuchi T; Mizunuma H
Clin Calcium; 2008 Oct; 18(10):1434-41. PubMed ID: 18830040
[TBL] [Abstract][Full Text] [Related]
18. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977
[TBL] [Abstract][Full Text] [Related]
19. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis.
Siminoski K; Josse RG
CMAJ; 1996 Oct; 155(7):962-5. PubMed ID: 8837547
[TBL] [Abstract][Full Text] [Related]
20. [Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis].
Ohta H
Clin Calcium; 2008 Oct; 18(10):1442-50. PubMed ID: 18830041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]